← Arcutis Biotherapeutics, Inc.
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | — | — | $0 | $0 | $0 | $3.7m |
$59.6m
+1517.09%
|
$196.5m
+229.74%
|
$376.1m
+91.34%
|
$464.0m
+23.38%
|
|
| Revenue from Contract with Customer, Including Assessed Tax | — | — | — | $0 | $0 | $3.7m | $59.6m | $166.5m | $372.1m | — | |
| Other revenue | — | — | — | — | — | $0 | $30.4m | $30.0m | $4.0m | — | |
| Cost of Revenue | — | — | $36.5m |
$0
-100.00%
|
$0 | $754k |
$5.0m
+561.41%
|
$19.1m
+283.56%
|
$36.7m
+91.84%
|
$41.1m
+11.99%
|
|
| Cost of sales | — | — | $36.5m |
$0
-100.00%
|
$0 | $754k |
$5.0m
+561.41%
|
$19.1m
+283.56%
|
$36.7m
+91.84%
|
$41.1m
+11.99%
|
|
| Gross Profit (Calculated) (derived) | — | — | ($36.5m) |
$0
+100.00%
|
$0 | $2.9m |
$54.6m
+1762.86%
|
$177.4m
+224.82%
|
$339.4m
+91.29%
|
— | |
| Research and Development Expense | — | $17.9m | $36.5m | $115.3m | $145.6m | $182.4m | $110.6m | $76.4m | $77.1m | $91.0m | |
| General and Administrative Expense | — | — | $6.6m | $21.3m | $61.0m | $122.1m | $185.1m | $229.4m | $274.6m | — | |
| Amortization of Intangible Assets | — | — | — | — | — | $312k | $750k | $2.0m | $4.7m | — | |
| Operating Lease, Expense | — | — | $151k | $602k | $686k | $716k | — | — | — | — | |
| Operating Expenses | — | $19.7m | $43.1m | $136.6m | $206.5m | $305.3m | $300.7m | $324.9m | $388.3m | $388.6m | |
| Loss from operations | — | ($19.7m) |
($43.1m)
-118.56%
|
($136.6m)
-216.81%
|
($206.5m)
-51.14%
|
($301.6m)
-46.05%
|
($241.1m)
+20.07%
|
($128.4m)
+46.75%
|
($12.2m)
+90.48%
|
— | |
| Operating Income (Loss) | — | ($19.7m) |
($43.1m)
-118.56%
|
($136.6m)
-216.81%
|
($206.5m)
-51.14%
|
($301.6m)
-46.05%
|
($241.1m)
+20.07%
|
($128.4m)
+46.75%
|
($12.2m)
+90.48%
|
$34.3m
+380.14%
|
|
| Interest Income, Other | — | — | — | — | — | — | $12.5m | $16.1m | $8.9m | $8.8m | |
| Other Nonoperating Income (Expense) | — | — | — | $967k | $173k | $5.8m | $11.8m | $16.2m | $443k | — | |
| Other income (expense), net | — | — | — | $967k | $173k | $5.8m | $11.8m | $16.2m | $443k | $53k | |
| Interest Expense (non-operating) | — | — | — | $0 | $0 | $15.7m | $29.7m | $27.2m | $12.1m | $13.8m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | — | — | — | $206.4m | $311.5m | ($255.7m) | ($130.4m) | ($8.2m) | $29.3m | |
| Loss before income taxes | — | — | — | — | ($206.4m) | ($311.5m) | ($259.0m) | ($139.4m) | ($15.0m) | — | |
| Provision for income taxes | — | — | $0 | $0 | $0 | $0 | $3.1m | $647k | $1.2m | — | |
| Current Income Tax Expense (Benefit) | — | — | — | — | — | — | $3.1m | $799k | $1.1m | $779k | |
| Net loss | — | ($19.3m) | ($42.0m) | ($135.7m) | ($206.4m) | ($311.5m) | ($262.1m) | ($140.0m) | ($16.1m) | — | |
| Net Income (Loss) Attributable to Parent | — | ($19.3m) |
($42.0m)
-118.10%
|
($135.7m)
-223.07%
|
($206.4m)
-52.09%
|
($311.5m)
-50.93%
|
($262.1m)
+15.83%
|
($140.0m)
+46.58%
|
($16.1m)
+88.47%
|
$28.5m
+276.69%
|
|
| Earnings Per Share, Basic | — | — | — | — | ($4.18) | ($5.66) | ($3.78) | ($1.16) | ($0.13) | $0.22 | |
| Earnings Per Share, Diluted | — | — | — | — | ($4.18) | ($5.66) | ($3.78) | ($1.16) | ($0.13) | $0.22 | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | 49.4m | 55.0m | 69.3m | 121.0m | 127.2m | 128.9m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | 49.4m | 55.0m | 69.3m | 121.0m | 127.2m | 131.9m | |
| Additional Financial Items | |||||||||||
| Costs and Expenses | — | — | — | — | — | — | $300.7m | $324.9m | $388.3m | — | |
| Income (Loss) Attributable to Parent, before Tax | — | — | — | — | — | — | ($259.0m) | ($139.4m) | ($15.0m) | — | |
| Unrealized gain on marketable securities | — | $0 | ($1k) | ($1k) | ($253k) | ($831k) | $1.2m | $219k | ($206k) | — | |
| Foreign currency translation adjustment | — | — | — | — | $0 | $0 | ($96k) | ($230k) | $169k | — | |
| Comprehensive loss | — | ($19.3m) | ($42.0m) | ($135.7m) | ($206.6m) | ($312.3m) | ($261.1m) | ($140.1m) | ($16.2m) | — | |
| Total other comprehensive income (loss) | — | — | — | — | ($253k) | ($831k) | $1.1m | ($11k) | ($37k) | — |